HONG KONG SAR - Media OutReach Newswire - 17 April 2026 - Clifford Kang, Vice President of SERES Group attended the 2026 ...
GUANGZHOU, CHINA - Media OutReach Newswire - 17 April 2026 - On April 15, the 139th China Import and Export Fair (hereinafter ...
SANYA, CHINA - Media OutReach Newswire - 17 April 2026 - As the 6th Asian Beach Games draws near, 4,680 youth volunteers, ...
MUNICH, GERMANY - Media OutReach Newswire - 17 April 2026 - The 18th edition of "Taicang Day" successfully convened at the ...
Trend Micro’s enterprise business accelerates its transformation as AI security category leaderHONG KONG SAR - - 17 April 2026 - ...
Middle East conflict has elevated strategic energy security priorities as countries seek supply diversification, ...
BitMEX, one of the safest crypto exchanges, announced today the launch of the TradFi Trade and Earn Campaign for users who ...
April 16, 2026Combining always-on spectral imaging with AI reconstruction to deliver enhanced levels of image quality, ...
First-ever demonstration of an end-to-end quantum-classical workflow for simulating complex therapeutics, unlocking a ...
SHANGPREE, Korea’s premier aesthetic skincare brand, is accelerating its global expansion by participating in ‘Beauty Asia’ in Singapore. Following recent successful launches on Amazon US and Jap ...
BEIJING, CHINA - Media OutReach Newswire - 16 April 2026 - With light and shadow flowing to carry forward the revolutionary ...
Boehringer Ingelheim today announced that The New England Journal of Medicine (NEJM) published results from the Phase 1b Beamion LUNG-1 trial of HERNEXEOS (zongertinib tablets) in treatment-naïve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results